| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.99B | 51.18B | 51.36B | 49.97B | 47.12B | 43.76B |
| Gross Profit | 29.18B | 29.39B | 29.64B | 28.43B | 27.27B | 25.40B |
| EBITDA | 2.46B | 3.02B | 3.46B | 3.19B | 3.85B | 2.83B |
| Net Income | 34.00M | 329.00M | 1.25B | 1.08B | 1.38B | 1.17B |
Balance Sheet | ||||||
| Total Assets | 34.55B | 35.47B | 36.17B | 36.19B | 36.65B | 35.47B |
| Cash, Cash Equivalents and Short-Term Investments | 11.97B | 13.60B | 14.16B | 13.82B | 14.52B | 13.42B |
| Total Debt | 300.00M | 1.12B | 1.42B | 1.69B | 2.07B | 2.58B |
| Total Liabilities | 5.71B | 6.55B | 7.03B | 7.03B | 7.56B | 7.28B |
| Stockholders Equity | 28.84B | 28.91B | 29.14B | 29.16B | 29.08B | 28.19B |
Cash Flow | ||||||
| Free Cash Flow | 736.00M | 1.08B | 2.60B | 1.43B | 2.71B | 489.00M |
| Operating Cash Flow | 2.20B | 2.03B | 3.56B | 2.21B | 3.42B | 2.76B |
| Investing Cash Flow | -1.86B | -1.40B | -1.24B | -1.08B | -1.01B | -2.50B |
| Financing Cash Flow | -1.08B | -1.19B | -1.98B | -1.84B | -1.31B | -733.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥14.29B | 24.48 | ― | 2.16% | 1.28% | 18.81% | |
73 Outperform | ¥52.65B | 8.14 | ― | 3.20% | 4.98% | -10.23% | |
64 Neutral | ¥33.64B | 7.86 | ― | 1.96% | 0.16% | 10.88% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥47.49B | 18.12 | 1.97% | 2.92% | 0.82% | 46.96% | |
48 Neutral | ¥13.95B | 4.68 | ― | 1.61% | 0.48% | -34.95% | |
46 Neutral | ¥37.70B | 21.75 | ― | 1.65% | -1.17% | -84.81% |